chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Chills, fever, fatigue.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test negative, Streptococcus test negative, Urticaria
Clinical narrative: Developed sore throat and hives one week after vaccine. Antibiotics helped sore throat, but hives persisted for two more weeks.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath, inability to fill lungs, happened nearly every day until treated.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema, Periorbital swelling
Clinical narrative: Extremely puffy upper and lower eyelids (eyelid edema). Still hasn?t gone down weeks later.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chills, Cough, Diarrhoea
Clinical narrative: Developed a Fever, Chills, Cough and nausea on 11/28. Went to ER on 12/01/21 and tested positive for Covid 19. Sent her home with no medications or oxygen. Developed severe nausea and bad diarrhea from 12/02/21 to 12/05/21. Went back to ER and was admitted for Covid Pneumonia on 12/05/21. Also developed bacterial pneumonia. Patient is currently still in the Hospital.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pneumonia bacterial, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Developed a Fever, Chills, Cough and nausea on 11/28. Went to ER on 12/01/21 and tested positive for Covid 19. Sent her home with no medications or oxygen. Developed severe nausea and bad diarrhea from 12/02/21 to 12/05/21. Went back to ER and was admitted for Covid Pneumonia on 12/05/21. Also developed bacterial pneumonia. Patient is currently still in the Hospital.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Product administered to patient of inappropriate age
Clinical narrative: The patient, was was 16 years old on the date of the adverse event, was vaccinated with the Moderna Booster Vaccine when the patient should have been given Pfizer. Patient experienced no symptoms or any adverse reaction to the vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Rash, Swelling face, Urticaria
Clinical narrative: Left side facial swelling Lip Swelling  Rash/hives all over the body  Presently using Benadryl
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Sore arm, body ache
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Pyrexia
Clinical narrative: Narrative: Patient states he recieved 2nd dose of Covid vaccine on Feb 26 and on March 11 he had fever, chills, and diarrhea that lasted for about 24hrs then went away. He wanted to document that he had a reaction to the vaccine.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dizziness, Myalgia
Clinical narrative: Narrative:  Patient experienced symptoms of chills, muscle aches, loss of appetite, and dizziness approximately one week after receiving the first COVID-19 vaccination dose.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Narrative:  A 68yo male with PMH of Extrinsic Asthma, Urithral Stricture, Rectal Bleeding, Cataract, Subjective Tinnitus, Sensorineural hearing loss, Opioid Depe. Remission, Diverticulitis, late Effects of Motor Vehicle Accident,  Esophageal Varices, Hepatitis C, Hepatic Cirrhosis, Chronic Postatitis He received Covid-19 on the right arm on March 6,2021 per protocol and was reported with post vaccine shot reactions of Chills, Muscle aches and head aches which started the following day after the vaccination
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Myalgia, Pyrexia
Clinical narrative: Narrative: Patient experienced dyspnea, muscle pain, fever, and headache after receiving the second dose of the COVID-19 vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Narrative: Patient experienced rash and itching after receiving the firs COVID-19 vaccination.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 58.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative: none stated
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None Stated.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Narrative: Patient is an 80 year old male. Only documentation regarding vaccine reaction was just "Bell's Palsy" written by provider
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received two doses of covid vaccine. patient has PMH of metastatic prostate cancer and died on hospice care. No other concerns of death reported related to vaccine given. Reporting per Regulatory Authority instruction.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Respiratory failure
Clinical narrative: Narrative: Patient with one covid vaccine. Patient passed from respiratory failure before second dose due. unclear the underlying cause from respiratory failure. No other death details recorded. reporting with Regulatory Authority instructions.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death
Clinical narrative: Narrative: Patient received two doses of covid vaccine. Patient reportedly died tw weeks after second dose from covid complications. No other details available. reporting per Regulatory Authority instructions.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt is a 72y.o. male who died on 05/13/2021 w/ h/o malignant neoplasm, overlapping lesion and solitary nodule of lung, HLD, GERD, and anxiety disorder. Pt. received J&J Covid-19 Vaccine 1/1 on 03/25/2021. Pt. died at Hospital on May 13,2021@16:42. Unlikely J&J Covid-19 vaccine contributed to pt death.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neutropenia, Neutrophil count decreased
Clinical narrative: Narrative:  Neutropenia....HX of CLL.Previously treated with ibrutinib,d/c'd 10/20. Transient decrease in patient's ANC: 1/5/21-1746 2/22/21-2019 3/2/21-1260 4/6/21-296 4/22/21-1572
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for hyperlipidemia, hypertension, CKD, anemia, prostate cancer, advanced age (95 years of age). No information regarding death or recent illnesses available.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Coronary artery disease, Death, Type 2 diabetes mellitus
Clinical narrative: Narrative: Death not suspected to be due to vaccine administration. Per death certificate, patient passed due to comorbid conditions including COPD, CAD, and T2DM.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt is an 87 YO male with PMH afib, CHF, anemia, CKD, DM, IHD, HTN, GERD, and Barret's esophagus seen by palliative care for HTN heart disease w/ HFrEF & CKD 3b. Per Regulatory Authority, pt's daughter reported t hat he passed away at home.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Respiratory failure
Clinical narrative: Narrative: Patient received two doses of COVID vaccine. Patient died on hospice, on hospice related to respiratory failure/PE. Patient developed covid within one week of first vaccine dose. No further reports of death documented.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt is a 68y.o. male who died on 04/22/2021 w/ h/o HTN, Hep C, Hypercalcemia, HLD, Elevated liver enzymes, Cholelithiasis, Hepatocellular carcinoma. Pt received Moderna Covid-19 Vaccination 2/2 on 03/08/2021. Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 69.0
Sex: M
Vaccine: FLU4
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder cancer, Death, Metastasis
Clinical narrative: Narrative:  Patient placed on Hospice and passed away due to complications of metastatic bladder cancer. Death not suspected to be related to administration of COVID-19 vaccine
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt was an 82 YO male with PHM of COPD, sleep apnea, CKD, DHF, NPH, DM, RA, HTN, and CAD. His death was reported to Hospital by Health Authority. No other details available.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for protein calories malnutrition, cortical myoclonus, fatty liver, Alzheimer dementia, HTN, hyperlipidemia, ckd stage 2. PT was on end of life palliative care at time of death and NPO. Pt deceased 4/29/21 at age 73 years of age.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: Narrative:  Patient received the 1st dose of the Moderna COVID-19 vaccine on 2/25/21. On 3/5/21 he advised his primary care provider of onset of a 2 inch in diameter rash at the injection site. Resolved without issue. He received the 2nd dose on 3/26/21 with no problems reported.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Computerised tomogram head, Dizziness, Electrocardiogram normal, Nausea
Clinical narrative: Narrative: Patient received the J&J COVID-19 vaccine on 3/30/21. On 4/6/21 patient awoke with acute onset of dizziness and nausea. He presented to a local ED for evaluation. Described a sensation of the "room is spinning" and resulting in nausea. Physical exam was unremarkable, but BP elevated 231/101. EKG normal. Head CT with no acute findings. Denies history of vertigo. Pt has diabetes, with recent history of hypoglycemia, but BG at the time not reported.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Narrative: Patient received the J&J COVID-19 vaccine on 3/30/21. On 4/6/21 patient awoke with acute onset of dizziness and nausea. He presented to a local ED for evaluation. Described a sensation of the "room is spinning" and resulting in nausea. Physical exam was unremarkable, but BP elevated 231/101. EKG normal. Head CT with no acute findings. Denies history of vertigo. Pt has diabetes, with recent history of hypoglycemia, but BG at the time not reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for HTN, hypercholesterolemia, GERD, Nodular prostate. Pt received first dose of Pfizer covid vaccine on 04/05/2021. Deceased on 4/25. No cause of death or any information regarding recent illness documented.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt is a 91 yo M with PMH of BPH, AMD, hearing loss, PVD, carotid artery occlusion, HLD, and DM. No indication in chart of cause of death; pt appears to receive primary care outside of this facility.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death, Resuscitation
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for dyslipidemia, cva, ventricular tachycardia s/p ablation, ischemic cardiomyopathy, coronary arteriosclerosis. PT was 74 years of age at time of death. Received 2nd dose pfizer 4/10/21. Per note on 4/21/21, patient was brought to a outside entity hospital with a CC of "Cardiac Arrest" . Received bystander CPR and brought via EMS. No further information regarding cause of death documented.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient received Moderna Covid #1 on 3/11/21 and #2 on 4/8/21. There are no scanned records or notes to indicate what happened from the date of second vaccine to date of death on 4/26/21. No autopsy reports. There were 18 days from time of second vaccine to date of death.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Death, Dyspnoea, Productive cough
Clinical narrative: Narrative: Pt is a 86y.o male who died on 05/02/2021 with a h/o COPD (3-4L O2 at home), R lung cancer s/p chemo/XRT and R lobectomy, Chronic diastolic HF with EF 54%, T1DM, HTN, CAD s/p PCI w/ DES to RCA. PPt received Moderna Covid-19 vaccination 2/2 on 02/17/2021. On 02/25/2021 pt presented to ED with c/o increased SOA. cough with yellow sputum, and dyspnea that started 3 days ago. Pt was discharged from ED on 02/25/2021 with physician noting patient has been with non-Hospital hospice for ~2 years. Pt presented for inpatient hospice admission on 04/30/2021. Physician reported in Death Note "Death was caused by: hypoxic respiratory failure secondary to end stage COPD" . Unlikely Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory failure, Sputum discoloured
Clinical narrative: Narrative: Pt is a 86y.o male who died on 05/02/2021 with a h/o COPD (3-4L O2 at home), R lung cancer s/p chemo/XRT and R lobectomy, Chronic diastolic HF with EF 54%, T1DM, HTN, CAD s/p PCI w/ DES to RCA. PPt received Moderna Covid-19 vaccination 2/2 on 02/17/2021. On 02/25/2021 pt presented to ED with c/o increased SOA. cough with yellow sputum, and dyspnea that started 3 days ago. Pt was discharged from ED on 02/25/2021 with physician noting patient has been with non-Hospital hospice for ~2 years. Pt presented for inpatient hospice admission on 04/30/2021. Physician reported in Death Note "Death was caused by: hypoxic respiratory failure secondary to end stage COPD" . Unlikely Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Cardio-respiratory arrest, Death, Diarrhoea, General physical health deterioration, Necrotising fasciitis
Clinical narrative: Narrative:  Patient received two doses of covid vaccine. PHM includes CAD, HTN, macrocytic anemia, CKD, OA requiring steroids who presented with 6 weeks of diarrhea. Upon admission, was found to have necrotizing fascitis of RLE and subsequently decompensated. Patient coded and was not able to survive. Reporting per Regulatory Authority instructions.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient received Moderna COVID #1 on 1/20/21 and #2 on 2/17/21. No information in chart on what happened from date of second vaccine to date of death of 3/31/21. Time from second vaccine to date of death is 42 days. No autopsy report available.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Death, Heart rate decreased, Tremor
Clinical narrative: Narrative:  Patient passed away in his home of Sat. 2/6/2021, family was present and 911 was called due to sudden and severe weakness/shakiness/decreased HR. Patient was ambulating with assistance and slumped over where he was pronounced deceased.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pruritus, Rash, Urticaria
Clinical narrative: Narrative:  Patient received first dose of Moderna COVID19 vaccine 1/22/21. No reported adverse effects. Second dose received 2/19/21. Patient presented to clinic 2/26 with chief complaint of intermittent rash/hives, itching since the day before, along with some nausea that morning. Denied shortness of breath, difficulty swallowing, wheezing and felt his normal self otherwise. Stated the rash was better that morning. Was prescribed prednisone, cetirizine, and ondansetron for outpatient pharmacy pick up and discharged from clinic. At PCP visit 3/24, symptoms had resolved and no additional treatment documented.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was previously COVID-19 positive and did not have any predisposing factors (PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 64 year old with a history of Heart Failure, Diabetes Mellitus II, Hypertension, Chronic Kidney Disease, GBS (2015),Depression, Low Back Pain. He was tested positive for COVID infection in March 2020. He declined hospitalization at that time. He had respiratory symptoms. He states he made a complete recovery. He also reports that he has kept himself isolated since that time. However, he tested positive again on admission on June 12 2020. He had dyspnea on presentation, but also had another explanation for the dyspnea, heart failure. On January 14, he developed violacious discolaration of his right hand, a skin finding associated with COVID. Other than this, he has been asymptomatic from the COVID infection. Pt was deceased on 4.12.2021.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspepsia, Headache, Nausea, Vomiting
Clinical narrative: Narrative:  Patient still reporting bad headaches daily since covid vaccine-pt reported this 4/1/2. The nausea/vomiting/indigestion have resolved.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Chest pain, Death, Depressed level of consciousness, Dyspnoea
Clinical narrative: Narrative: Pt is a 74y.o. male who died on 04/29/2021 with h/o Polycystic Kidney Disease, ESRD on HD MWF, HFpEF (49% on 11/05/20), DM2 w/ neuropathy and retinopathy (legally blind), OSA (non-compliant with bipap), HTN, HLD, GERD, anemia of chronic disease, depression w/ h/o SI, cervical spondylosis, prostate ca (in remission), and lt distal supracondylar femoral fracture s/p fixation (11/2020), with very frequent hospitalizations over the past year related to complications of ESRD and non-compliance with dialysis. Pt received Moderna Covid-19 vaccination on 4/12/2021. Pt presented to the ED 4/24/21 from dtr's home c/o soa and chest pain x 3 hours. He was admitted for NSTEMI and PNA (w/ pleurisy). NSTEMI, hyperkalemia, and PNA. He developed hypoxia, hypercarbia, and obtunded mental status on 4/26/21, and was placed on bipap. Patient's hypercarbia and alertness improved, however he is now refusing to continue wearing bipap. Per renal team, patient's respiratory acidosis is not likely to improve with dialysis, as it is primarily 2/2 CO2 retention. Palliative medicine is consulted for goals of care discussion. Pt died on 04/29/2021 at 0436 with physician reporting in Death Note "Death was caused by: Acute hypercapnic respiratory failure". Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Hypercapnia, Hyperkalaemia, Hypoxia, Pleurisy, Pneumonia
Clinical narrative: Narrative: Pt is a 74y.o. male who died on 04/29/2021 with h/o Polycystic Kidney Disease, ESRD on HD MWF, HFpEF (49% on 11/05/20), DM2 w/ neuropathy and retinopathy (legally blind), OSA (non-compliant with bipap), HTN, HLD, GERD, anemia of chronic disease, depression w/ h/o SI, cervical spondylosis, prostate ca (in remission), and lt distal supracondylar femoral fracture s/p fixation (11/2020), with very frequent hospitalizations over the past year related to complications of ESRD and non-compliance with dialysis. Pt received Moderna Covid-19 vaccination on 4/12/2021. Pt presented to the ED 4/24/21 from dtr's home c/o soa and chest pain x 3 hours. He was admitted for NSTEMI and PNA (w/ pleurisy). NSTEMI, hyperkalemia, and PNA. He developed hypoxia, hypercarbia, and obtunded mental status on 4/26/21, and was placed on bipap. Patient's hypercarbia and alertness improved, however he is now refusing to continue wearing bipap. Per renal team, patient's respiratory acidosis is not likely to improve with dialysis, as it is primarily 2/2 CO2 retention. Palliative medicine is consulted for goals of care discussion. Pt died on 04/29/2021 at 0436 with physician reporting in Death Note "Death was caused by: Acute hypercapnic respiratory failure". Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Refusal of treatment by patient, Respiratory acidosis, Respiratory failure
Clinical narrative: Narrative: Pt is a 74y.o. male who died on 04/29/2021 with h/o Polycystic Kidney Disease, ESRD on HD MWF, HFpEF (49% on 11/05/20), DM2 w/ neuropathy and retinopathy (legally blind), OSA (non-compliant with bipap), HTN, HLD, GERD, anemia of chronic disease, depression w/ h/o SI, cervical spondylosis, prostate ca (in remission), and lt distal supracondylar femoral fracture s/p fixation (11/2020), with very frequent hospitalizations over the past year related to complications of ESRD and non-compliance with dialysis. Pt received Moderna Covid-19 vaccination on 4/12/2021. Pt presented to the ED 4/24/21 from dtr's home c/o soa and chest pain x 3 hours. He was admitted for NSTEMI and PNA (w/ pleurisy). NSTEMI, hyperkalemia, and PNA. He developed hypoxia, hypercarbia, and obtunded mental status on 4/26/21, and was placed on bipap. Patient's hypercarbia and alertness improved, however he is now refusing to continue wearing bipap. Per renal team, patient's respiratory acidosis is not likely to improve with dialysis, as it is primarily 2/2 CO2 retention. Palliative medicine is consulted for goals of care discussion. Pt died on 04/29/2021 at 0436 with physician reporting in Death Note "Death was caused by: Acute hypercapnic respiratory failure". Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Narrative:  2 days after patient received his first covid vaccination, pattient experience a rash on both forearms
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received Moderna Covid #1 on 3/12/21. There are no further notes or scanned records to indicate what happened between this date and his recorded date of death of 4/19/21. No autopsy report available. There were 38 days from time of first vaccine to date of death.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for Atrial fibrillation, chronic failure syndrome, hypertension. Patient deceased at 88 years of age at outside entity hospital. No documentation regarding hospital stay or cause of death available.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Death, Endotracheal intubation, Intensive care, Pulmonary mass
Clinical narrative: Narrative:  Patient received Moderna Covid #1 on 2/13/21 and #2 on 3/13/21. On 4/3/21, he was seen in our ER for a skin lesion that had been present x 2 months on his left lower chest. He was given a tetanus shot and referred to dermatology. On 4/7/21, he was taken to a facility after he was found unresponsive and pulseless by his wife. He was down for an unknown amount of time. He was admitted to the ICU and intubated. He was seen by cardiology and neurology and suspected cause of event was hypoxic/hypercapnic respiratory failure. He also had a CT of the chest while there and was found to have a lung mass, noted history of COPD. He was given Solumedrol, Duonebs, fentanyl, Propofol and cefepime/vancomycin (for pneumonia/COPD exacerbation). He remained there until his date of death of 4/10/21. No autopsy reports available. Time from 2nd vaccine to date of death was 28 days.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulse absent, Respiratory failure, Skin lesion, Unresponsive to stimuli
Clinical narrative: Narrative:  Patient received Moderna Covid #1 on 2/13/21 and #2 on 3/13/21. On 4/3/21, he was seen in our ER for a skin lesion that had been present x 2 months on his left lower chest. He was given a tetanus shot and referred to dermatology. On 4/7/21, he was taken to a facility after he was found unresponsive and pulseless by his wife. He was down for an unknown amount of time. He was admitted to the ICU and intubated. He was seen by cardiology and neurology and suspected cause of event was hypoxic/hypercapnic respiratory failure. He also had a CT of the chest while there and was found to have a lung mass, noted history of COPD. He was given Solumedrol, Duonebs, fentanyl, Propofol and cefepime/vancomycin (for pneumonia/COPD exacerbation). He remained there until his date of death of 4/10/21. No autopsy reports available. Time from 2nd vaccine to date of death was 28 days.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anaemia, Aspiration pleural cavity, Chronic obstructive pulmonary disease, Condition aggravated, Death
Clinical narrative: Narrative: Pt is a 86y.o. male who died on 05/14/2021 w/ h/o colon cancer resected in 2010, COPD, HTN, CAD s/p PCI 8-10 years ago, CHF (EF 46% on echo in 5/2019), and and recent pleural effusion with thoracentesis 2 weeks ago. Notable "smoker since age 5 1/2." Recently smoked 3 cigs/day (04/29/2021). Pt received Moderna Covid-19 Vaccination 2/2 on 03/25/2021. Pt presented to ED on 04/29/2021after two episodes at home of facial flushing and shortness of breath. Pt diagnosed w/ Multifactorial Dyspnea, Acute on chronic anemia, Recurrent Pleural Effusion, Tachycardia, COPD Exacerbation and admitted on 05/01/2021. Pt consented to life-sustaining treatment on 05/05/2021. Discharged to outpatient hospice on 05/12/2021. Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Flushing, Pleural effusion, Tachycardia
Clinical narrative: Narrative: Pt is a 86y.o. male who died on 05/14/2021 w/ h/o colon cancer resected in 2010, COPD, HTN, CAD s/p PCI 8-10 years ago, CHF (EF 46% on echo in 5/2019), and and recent pleural effusion with thoracentesis 2 weeks ago. Notable "smoker since age 5 1/2." Recently smoked 3 cigs/day (04/29/2021). Pt received Moderna Covid-19 Vaccination 2/2 on 03/25/2021. Pt presented to ED on 04/29/2021after two episodes at home of facial flushing and shortness of breath. Pt diagnosed w/ Multifactorial Dyspnea, Acute on chronic anemia, Recurrent Pleural Effusion, Tachycardia, COPD Exacerbation and admitted on 05/01/2021. Pt consented to life-sustaining treatment on 05/05/2021. Discharged to outpatient hospice on 05/12/2021. Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Brain cancer metastatic, Condition aggravated, Death, Disease complication, Fall
Clinical narrative: Narrative: Pt is a 68y.o male who died on 05/14/2021 w/ h/o COPD, DM-2, HTN, HLD and R ICA stenosis, and metastatic large cell neuroendocrine tumor with diffuse mets to the liver. Notable for 1 ppd smoker since age 10 with intermittent quitting periods (40 pack year smoker). Pt received Jansen Covid-19 Vaccination 1/2 on 03/13/2021. Pt admitted for inpatient hospice care on 05/10/2021 at wife request due to due to metastatic brain cancer, increasing jaundice and falls at home. Pt died on 05/14/2021 with calling physician reporting "Death was caused by: complications of malignancy from poorly differentiated Neuroendocrine carcinoma". Unlikely Jansen Covid-19 vaccine caused/contributed to pt death.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Jaundice, Neuroendocrine carcinoma
Clinical narrative: Narrative: Pt is a 68y.o male who died on 05/14/2021 w/ h/o COPD, DM-2, HTN, HLD and R ICA stenosis, and metastatic large cell neuroendocrine tumor with diffuse mets to the liver. Notable for 1 ppd smoker since age 10 with intermittent quitting periods (40 pack year smoker). Pt received Jansen Covid-19 Vaccination 1/2 on 03/13/2021. Pt admitted for inpatient hospice care on 05/10/2021 at wife request due to due to metastatic brain cancer, increasing jaundice and falls at home. Pt died on 05/14/2021 with calling physician reporting "Death was caused by: complications of malignancy from poorly differentiated Neuroendocrine carcinoma". Unlikely Jansen Covid-19 vaccine caused/contributed to pt death.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination failure
Clinical narrative: Narrative:  VACCINATION FAILURE
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccination failure
Clinical narrative: Narrative: VACCINATION FAILURE
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Confusional state, Death, Hepatic cirrhosis
Clinical narrative: Narrative: Patient was admitted to acute care services 3/21/21 to 3/24/21 due to hepatic failure/cirrhosis. On 3/22/21, he had a paracentesis. On 3/24/21 he received Moderna Covid #1 and discharged home with family. Note indicate that he was in the process of being evaluated for placement on the liver transplant list. On 4/4/21, he presented to our ER with c/o weakness and abdominal pain and had a paracentesis done in the ER that did not show SBP. He was subsequently admitted to MED and given albumin, Zosyn and lactulose. On 4/8/21, it was noted that his caregiver states that they cannot care for him at home due to increasing confusion. This same day it was also noted that he was denied placement on the liver transplant list and an hospice consult was placed. He was made hospice in place and received comfort care medications. On 4/16/21, he passed away. Autopsy was declined. Time from vaccine to date of death was 23 days.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatic failure, Paracentesis
Clinical narrative: Narrative: Patient was admitted to acute care services 3/21/21 to 3/24/21 due to hepatic failure/cirrhosis. On 3/22/21, he had a paracentesis. On 3/24/21 he received Moderna Covid #1 and discharged home with family. Note indicate that he was in the process of being evaluated for placement on the liver transplant list. On 4/4/21, he presented to our ER with c/o weakness and abdominal pain and had a paracentesis done in the ER that did not show SBP. He was subsequently admitted to MED and given albumin, Zosyn and lactulose. On 4/8/21, it was noted that his caregiver states that they cannot care for him at home due to increasing confusion. This same day it was also noted that he was denied placement on the liver transplant list and an hospice consult was placed. He was made hospice in place and received comfort care medications. On 4/16/21, he passed away. Autopsy was declined. Time from vaccine to date of death was 23 days.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Dyspnoea, Gait disturbance
Clinical narrative: Narrative:  Presented to the ED at Hospital on 4/14/21 with shortness of breath, was hypoxic on presentation. Saturation in the 80's on 4 L oxygen by NC. CXR with small area of focal infiltrate in the right lung. CT chest showed extensive bilateral PE with potential right heart strain. Patient was admitted to ICU and has right pulmonary artery thrombectomy and a large amount of clot was removed and right lung was reperfused. He was started on Apixaban and sent to acute rehabilitation at Healthcare center from where he was discharged yesterday.. Patient has advanced parkinsonsian features including impaired gait, slow muffled speech and mask like facies. Of note, this episode of PE was 2 weeks out from the 2nd shot of Pfizer COVID vaccine that the patient received on 03/29.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Intensive care, Lung infiltration, Pulmonary embolism, Reduced facial expression
Clinical narrative: Narrative:  Presented to the ED at Hospital on 4/14/21 with shortness of breath, was hypoxic on presentation. Saturation in the 80's on 4 L oxygen by NC. CXR with small area of focal infiltrate in the right lung. CT chest showed extensive bilateral PE with potential right heart strain. Patient was admitted to ICU and has right pulmonary artery thrombectomy and a large amount of clot was removed and right lung was reperfused. He was started on Apixaban and sent to acute rehabilitation at Healthcare center from where he was discharged yesterday.. Patient has advanced parkinsonsian features including impaired gait, slow muffled speech and mask like facies. Of note, this episode of PE was 2 weeks out from the 2nd shot of Pfizer COVID vaccine that the patient received on 03/29.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Speech disorder, Thrombectomy
Clinical narrative: Narrative:  Presented to the ED at Hospital on 4/14/21 with shortness of breath, was hypoxic on presentation. Saturation in the 80's on 4 L oxygen by NC. CXR with small area of focal infiltrate in the right lung. CT chest showed extensive bilateral PE with potential right heart strain. Patient was admitted to ICU and has right pulmonary artery thrombectomy and a large amount of clot was removed and right lung was reperfused. He was started on Apixaban and sent to acute rehabilitation at Healthcare center from where he was discharged yesterday.. Patient has advanced parkinsonsian features including impaired gait, slow muffled speech and mask like facies. Of note, this episode of PE was 2 weeks out from the 2nd shot of Pfizer COVID vaccine that the patient received on 03/29.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received Moderna Covid #1 on 3/6/21 and #2 on 4/2/21. No scanned records or notes that indicate what happened between his second vaccine and date of death on 4/4/21. Noted his ESRD on dialysis and was on the kidney transplant list. Time from second vaccine to date of death was 2 days. no autopsy report available.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Craniectomy, Death, Deep vein thrombosis, Headache, Meningitis
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for hx of subdural intracranial hematoma, cognitive disorder, functional gait abnormality, dysphagia with peg tube placement. Patient was taken to outside entity hospital on 4/30/21 with CC of blurriness and headache. Was admitted and diagnosed with meningitis. Craniectomy and washout performed 5/1. Also suffered from P/E and DVT. Patient deceased 5/13/2021. Lack of information regarding death and hospital records.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism, Vision blurred
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for hx of subdural intracranial hematoma, cognitive disorder, functional gait abnormality, dysphagia with peg tube placement. Patient was taken to outside entity hospital on 4/30/21 with CC of blurriness and headache. Was admitted and diagnosed with meningitis. Craniectomy and washout performed 5/1. Also suffered from P/E and DVT. Patient deceased 5/13/2021. Lack of information regarding death and hospital records.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoptysis, Malaise, Pneumonia, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Narrative:  Patient received Moderna Covid dose #1 vaccine 3/6/21 and then reported hemoptysis/fever/malaise on 3/16- 10 days after dose. Patient presented to urgent care, covid test was negative. They referred him to ER, patient was treated with doxycycline, diagnosis of pneumonia in the left lung. Unlikely the two events are related.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Headache, Malaise
Clinical narrative: Narrative:  Patient received Moderna vaccine #1 on 3/19- reported malaise, headache and chest pain the next 48 hours. By 72 hours post vaccine, symptoms had completely resolved. Patient did get the second vaccination.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for heart murmur, COPD, sleep apnea, DM, hyperlipidemia, HTN. Lack of information regarding death. Patient deceased 3/31/2021 at age 85 per wife.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Pain in extremity, Peripheral swelling
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient is a 62 years old female with past medical history of Hypertension, Neuropathy, Hypothyroidism, CAD, DVT, Alcohol abuse, Nicotine dependence, Cachexia. Per follow up note on 4.9.21 patient had uncontrolled blood pressure, and dramatically lost weight over last 2 years. Patient also smoked 1/2 to 1 pack per day. Per notes from last few months patient had problem with leg swelling and pain which was not resolving. Patient was started on Chlorthalidone and for DVT txt patient was on Apixaban. Patient had history of fracture to left tibial plateau in sept 2020. Other than this there were no note found on chart for ER visit or hospitalization recently. Patient passed away on 5.8.2021.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Death, Peripheral coldness, Pulse absent, Respiratory arrest
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for abnormal liver function, cocaine use, ischemic cardiomyopathy, chronic alcoholism, hypertension, bipolar disorder, chronic obstructive lung disease, hyperlipidemia, GERD, CAD, homelessness. Per note 5/5, patient was found deceased in chair on 4/27, cold to the touch and not breathing with no pulse. Immediate cause of death "probably acute myocardial infarction" However no other documentation regarding death confirms this.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Narrative:  Author inquired about patient's well-being and the presence of side effects.  Patient had some malaise, but denies fever, chills, body aches, and other symptoms. Author advised sister to notify primary care RN triage line in the event patient feels worse.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Death, Discharge, Erythema, Oedema
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for vitamin d deficiency, CAD, asthma, hyperlipidemia mixed, Atrial fibrillation, ckd stage 3, HTN. T2DM, gout, CHF, renal stenosis, cardiac pacemaker, advanced age (90 Years of age). Pt arrived at ED on 4/28/21 with a CC of leg swelling, redness, drainage and pain. Pt has worsening edema over the previous few months. In ED received vancomycin. Was transferred to another facility for vascular eval. on 5/8 readmited for generalized weakness and pain. Patient and family wished to be kept comfortable. Deceased 5/11
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for vitamin d deficiency, CAD, asthma, hyperlipidemia mixed, Atrial fibrillation, ckd stage 3, HTN. T2DM, gout, CHF, renal stenosis, cardiac pacemaker, advanced age (90 Years of age). Pt arrived at ED on 4/28/21 with a CC of leg swelling, redness, drainage and pain. Pt has worsening edema over the previous few months. In ED received vancomycin. Was transferred to another facility for vascular eval. on 5/8 readmited for generalized weakness and pain. Patient and family wished to be kept comfortable. Deceased 5/11
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder cancer, Death, Disease complication, Shock haemorrhagic
Clinical narrative: Narrative:  Patient passed away from complications from bladder cancer and hemorrhagic shock. Death not thought to be related to administration of COVID-19 vaccine.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death
Clinical narrative: Narrative: Death certificate indicated Pt passed from probable cardiac arrest due to history of CAD.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  No documentation found in chart review indicating that death was related to COVID-19 vaccine administration
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral haemorrhage, Death, Fall
Clinical narrative: Narrative:  Patient passed away after trying to climb the stairs and falling. He was taken to the Emergency Department and ultimately passed away from a brain bleed.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Narrative:  Patient reported mild nausea that started 24 hours after second dose of Moderna vaccine. Within 24 hours of the start, symptoms resolved.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Laboratory test abnormal
Clinical narrative: Narrative:  PATIENT WITH COVID-19 INFECTION FOLLOWING BEING FULLY VACCINATED. PATIENT REQUIRED AN INPATIENT STAY WITH HIGH-FLOW OXYGEN, REMDESIVIR, DEXAMETHASONE AND TOCILZUMAB TREATMENT. FURTHER LAB TESTING SHOWED UK STRAIN OF COVID-19.
Age: 103.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient passed away peacefully in his sleep. Was on Hospice due to CAD and CHF.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient reported death after covid vaccine. 2 doses received. No other documentation listed in chart or reports of death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Disease progression, Neoplasm malignant
Clinical narrative: Narrative:  Patient died due to complications of progressing cancer. No suspected that COVID-19 administration played any role in death.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient received two doses of covid vaccine. Passed one day after second dose. PMH includes dementia, cad, chf c/b severe aortic stenosis, htn, depression. No further documentation of cause of death or complications of receiving the vaccine.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received 2 doses of covid vaccine. Patient was recently in hospital before death. PMH includes decompensated cirrhosis, ascites, melena. Patient has no documentation of death recorded. No documentation of concern of covid vaccine relating to death. Reporting per network instruction.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Accident, Death, Drowning
Clinical narrative: Narrative:  Pt is a79y.o. male who died on 05/08/2021 w/ h/o metastatic prostate cancer, DVT (07/2020), CHF, depression, HLD, HTN, BPH. Pt received Moderna Covid-19 Vaccination 2/2 on 03/210/2021. Pt's Caregiver reports the patient had a "freak accident". She states that he was mowing the lawn on a 0 turn lawn mower and somehow lost control of the lawn mower and it drove into their pond. Patient drowned in the pond. Unlikely Moderna Covid-19 Vaccine caused/contributed to pt death.
Age: 93.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt is a 92y.o. male who died on 05/08/2021 w/ h/o CHG, CAD, HLD, GERD, DM, BPH. Pt received Moderna Covid-19 Vaccination 2/2 on 05/05/2021. Pt began receiving hospice care starting on 03/19/2021. Pt did not want anymore hospitalizations, no more test, no IV AB. His wishes are to remain in his home and be comfortable. Unlikely Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 92.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt is a 91 male who died on 05/09/2021 w/h/o CKD, GERD, HLD, and HTN. Pt received Moderna Covid-19 vaccination 2/2 on 02/08/2021. Pt died on 05//09/2021 at hospital. Unlikely Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient is a 73YO M with COPD, tobacco use, Crohn's disease, DM (Type II), GERD, CKD stage 3, Malignant tumor of lung, Obesity, Hyperuricemia, Iron deficiency anemia. Discharge notes from 2.5.21 says recent diagnosis with a cavitary RUL lung lesion who was admitted to the hospital for further evaluation for mycobacterial infection. He was recently hospitalized, where the lung lesion was incidentally noted during preop evaluation prior to patient undergoing repair of an incarcerated umbilical hernia. For NSCLC patient was getting treatment Chemo treatment. Per 2/17 notes patient requested to go to hospice. Patient was deceased on 5.6.2021.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pruritus
Clinical narrative: Narrative:  Pruritus, dizziness 30 min after getting vaccine. Patient observed in ED and given diphenhydramine.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt is a 68y.o. male who died on 05/132021 w/ h/o HTN. CAD, GERD, COPD, AFib, Diabetes, and Schizophrenia. Pt received Moderna Covid-19 Vaccination 2/2 on 05/05/2021. On 05/13/2021 CM arrived to patients home today at 9:30am for a scheduled transport and escort to surgery. Patient did not answer the phone or his door which is not usual for patient. CM consulted with Supervisor and contacted patient next of kin for a recommended wellness check. Patient was found deceased in his home by his brother. Unlikely Moderna Covid-19 vaccine caused/contribute to pt death.